2025
Challenges to Adolescent Pre-exposure Prophylaxis (PrEP) Uptake: an Exploration of Black and Latino American Parents’ Beliefs, Attitudes, and Receptivity to PrEP
Albritton T, Coulibaly K, Taggart T, Bartholomew Z, Oridota O, Springer E, Munoz-Laboy M, Pina P. Challenges to Adolescent Pre-exposure Prophylaxis (PrEP) Uptake: an Exploration of Black and Latino American Parents’ Beliefs, Attitudes, and Receptivity to PrEP. Journal Of Racial And Ethnic Health Disparities 2025, 1-12. PMID: 40779140, DOI: 10.1007/s40615-025-02567-7.Peer-Reviewed Original ResearchPrEP uptakeMedical mistrustLack of PrEP awarenessHIV prevention initiativesBackgroundPre-exposure prophylaxisPre-exposure prophylaxisTeen Health ClinicsPrEP awarenessHealth practicesHealth clinicsLatino adolescentsFocus groupsImpact of family factorsPrevention initiativesEmergent themesLatino communitiesPrEPNew York CityFinancial burdenFamily factorsMinoritized communitiesParental beliefsYork CityParental consentAdolescents“Am I Truly Invisible?”: Black Women's Experiences of and Coping With Intersectional Invisibility in Uterine Fibroid Treatment
Malekzadeh A, Zota A, Lyons M, Taggart T. “Am I Truly Invisible?”: Black Women's Experiences of and Coping With Intersectional Invisibility in Uterine Fibroid Treatment. Women's Health Issues 2025 PMID: 40628590, PMCID: PMC12243959, DOI: 10.1016/j.whi.2025.05.005.Peer-Reviewed Original ResearchHealth care settingsCare settingsIntersectional invisibilityBlack women's experiencesBlack womenWomen's experiencesThematic analytic approachSocial-structural inequitiesHealth inequalitiesHealth outcomesSocial supportSuperwoman SchemaBlack women’s voicesGendered RacismHealthWomen's voicesObservational researchParticipantsRacismInvisibilitySexismWomenProjection strengthFibroid treatmentInequalityLeveraging U = U in Interventions for Black Women Living With HIV: A Scoping Review and Call To Action
Jones M, Sawyer S, Bowman I, Habib M, Wassertzug D, Taggart T. Leveraging U = U in Interventions for Black Women Living With HIV: A Scoping Review and Call To Action. AIDS And Behavior 2025, 29: 2077-2087. PMID: 40029580, DOI: 10.1007/s10461-025-04670-6.Peer-Reviewed Original ResearchParadox of Progress: NIH-Funded Research on Sexual and Gender Minority Populations, 2012-2022.
Friedman M, Taggart T, Coulter R. Paradox of Progress: NIH-Funded Research on Sexual and Gender Minority Populations, 2012-2022. American Journal Of Public Health 2025, 115: 255-258. PMID: 39938041, PMCID: PMC11845834, DOI: 10.2105/ajph.2024.307986.Peer-Reviewed Original ResearchP-1415. Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic
Kerrigan D, Scott R, O’Rourke A, Galai N, Karver T, Davis W, Metzner A, Oglesby A, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y. P-1415. Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.1590. PMCID: PMC11777370, DOI: 10.1093/ofid/ofae631.1590.Peer-Reviewed Original ResearchPre-exposure prophylaxisLong-actingFemale sex workersSocial determinantsCisgender womenSocial determinants of healthHIV diagnosis ratesDaily oral PrEPDeterminants of healthBlack cisgender womenLow pre-exposure prophylaxisCross-sectional surveyOral PrEPUnited StatesHIV disparitiesWhite cisgender womenHIV inequitiesSide effectsIncreased oddsDiagnosis rateHIVPrEP preferencesDominican RepublicPrEPSex workersP-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
Metzner A, Oglesby A, O’Rourke A, Galai N, Karver T, Davis W, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y, Kerrigan D. P-500. Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic. Open Forum Infectious Diseases 2025, 12: ofae631.699. PMCID: PMC11779361, DOI: 10.1093/ofid/ofae631.699.Peer-Reviewed Original ResearchHIV pre-exposure prophylaxisFemale sex workersOral PrEPPre-exposure prophylaxisLAI-PrEPDaily oral PrEPNumbers of sex partnersReproductive health clinicsSexual health clinicsHealth clinicsCisgender womenAcquired HIVHIV acquisitionLong-actingDaily pillInjectable PrEPPrEP clinicPrimary care clinicsPrEP useLatina ethnicityCondom useHIV knowledgeSex partnersPrEP awarenessHIV
2024
PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA
Taggart T, Mathews A, Junious T, Lindsey J, Augustine A, Debnam C, Boyd Y, Wright S, Tucker J, Magnus M. PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA. PLOS ONE 2024, 19: e0313882. PMID: 39556546, PMCID: PMC11573147, DOI: 10.1371/journal.pone.0313882.Peer-Reviewed Original ResearchConceptsPrEP messagingSemi-structured interviewsHigh risk of HIVCommunity engagementCrowdsourced messagesYoung peopleCross-sectional surveyRisk of HIVPre-exposure prophylaxisPublic health impactImplementation researchPromote PrEPHIV preventionMedical providersConvenience sampleHIV incidenceCommunity partnersPromotion messagesEngaging young peopleWorld Health OrganizationThematic codingSurvey participantsPrEPHealth impactsSocial marketingIdentifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach
Gullahorn B, Kuo I, Robinson A, Bailey J, Loken J, Taggart T. Identifying facilitators and barriers to the uptake of medication for opioid use disorder in Washington, DC: A community-engaged concept mapping approach. PLOS ONE 2024, 19: e0306931. PMID: 39028730, PMCID: PMC11259286, DOI: 10.1371/journal.pone.0306931.Peer-Reviewed Original ResearchConceptsConcept mapping approachOpioid use disorderUptake of medicationCommunity advisory boardStigma associated with substance useUse disorderPublic health challengeAwareness of treatmentMOUD deliverySense of hopelessnessIdentified barriersUnique statementsHealth challengesAdvisory BoardOpioid overdoseProvidersCommunity membersMOUD engagementMOUDSubstance useTreatment programsHopelessnessMedicationPersonal motivationFacilitationReligion, Spirituality, and COVID-19
Ransome Y, Taggart T, Kawachi I. Religion, Spirituality, and COVID-19. 2024, 395-419. DOI: 10.1093/oso/9780197625217.003.0016.Peer-Reviewed Original ResearchReligious service attendanceService attendanceLevels of religious service attendanceConstructs of religiosityReading scriptureReligious textsReligious practicesPrivate religiosityReligious effectsSpecific traditionsReligionReligiositySocial relationsCOVID-19 health outcomesEucharistScriptureCommunionGoodsSpiritualityTraditionRitualsMeditationOrganizational aspectsTextPurview
2023
1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers
Davis W, Mantsios A, Metzner A, Talan A, Kwait J, Rodriguez H, Karver T, Barker S, Suarez A, Fernandez R, Rodriguez-Diaz C, Taggart T, Oglesby A, Garris C, Wohl D, Barrington C, Kerrigan D. 1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers. Open Forum Infectious Diseases 2023, 10: ofad500.1371. PMCID: PMC10677220, DOI: 10.1093/ofid/ofad500.1371.Peer-Reviewed Original ResearchPre-exposure prophylaxisHealthcare providersLA PrEPInjectable pre-exposure prophylaxisHIV pre-exposure prophylaxisExit interviewsPrEP conversationsClinic visitsPrEP knowledgePrEP useClinical visitsViiV HealthcarePrEP usersHIV preventionSide effectsFDA approvalCare optionsPrEPAcceptable deliveryKnowledge deficitsFormative researchProphylaxisVisitsMinor suggestionsDiverse populations1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors
Kerrigan D, Yonamine K, O’Rourke A, Karver T, Davis W, Metzner A, Oglesby A, Garris C, Scott R, Moriarty P, Taggart T, Barrington C, Gomez H, Perez M, Donastorg Y. 1843. Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Roles of Social-Structural Factors. Open Forum Infectious Diseases 2023, 10: ofad500.1671. PMCID: PMC10678848, DOI: 10.1093/ofid/ofad500.1671.Peer-Reviewed Original ResearchSocial structural factorsFemale sex workersCisgender womenDominican RepublicHIV pre-exposure prophylaxisUnited StatesLA PrEPSocial structural constraintsNew HIV infectionsReproductive health servicesGender normsHealthcare providersInjectable PrEPThematic content analysisPrEP uptakeDepth interviewsHIV infectionPartner dynamicsSex workersEmpowerment toolReproductive healthcare providersDisproportionate impactPre-exposure prophylaxisTransgender womenContent analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply